Aliases & Classifications for Syncope

About this section

Aliases & Descriptions for Syncope:

Name: Syncope 49 27 2

Summaries for Syncope

About this section
NINDS:49 Syncope is a medical term used to describe a temporary loss of consciousness due to the sudden decline of blood flow to the brain. Syncope is commonly called fainting or ?passing out.? If an individual is about to faint, he or she will feel dizzy, lightheaded, or nauseous and their field of vision may ?white out? or ?black out.?

MalaCards based summary: Syncope is related to jervell and lange-nielsen syndrome and atrial fibrillation, familial, 3. An important gene associated with Syncope is SLC6A2 (Solute Carrier Family 6 Member 2), and among its related pathways are Antiarrhythmic Pathway, Pharmacodynamics and SIDS Susceptibility Pathways. Affiliated tissues include testes, brain and heart, and related mouse phenotype muscle.

Wikipedia:71 Syncope may refer to one of the following: more...

Related Diseases for Syncope

About this section

Diseases related to Syncope via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 274)
idRelated DiseaseScoreTop Affiliating Genes
1jervell and lange-nielsen syndrome30.8CALM1, CALM2, KCNH2, KCNQ1, SCN5A
2atrial fibrillation, familial, 330.8KCNH2, KCNQ1, SCN5A
3long qt syndrome 1430.3CALM1, CALM2, CALM3
4long qt syndrome 1530.3CALM1, CALM2, CALM3
5second-degree atrioventricular block29.1KCNH2, KCNQ1, SCN5A
6syncope, familial vasovagal12.1
7ventricular extrasystoles with syncope, perodactyly, and robin sequence11.8
8ventricular extrasystoles with syncopal episodes - perodactyly - robin sequence11.8
9catecholaminergic polymorphic ventricular tachycardia11.5
10ventricular tachycardia, catecholaminergic polymorphic, 111.5
11ventricular tachycardia, catecholaminergic polymorphic, 211.4
12ventricular tachycardia, catecholaminergic polymorphic, 411.4
13fainting11.2
14orthostatic intolerance11.0
15brugada syndrome10.9
16postural hypotension10.9
17long qt syndrome 110.8
18vulvar vestibulitis syndrome10.8
19long qt syndrome 910.7
20sinoatrial node dysfunction and deafness10.7
21long qt syndrome-310.7
22heart block, progressive, type ia10.7
23sick sinus syndrome 110.7
24dementia, lewy body10.7
25cardiac arrhythmia, ankyrin-b-related10.7
26long qt syndrome-1110.7
27long qt syndrome 210.7
28long qt syndrome-1010.7
29long qt syndrome 1310.7
30sick sinus syndrome 310.7
31long qt syndrome 1210.7
32long qt syndrome 610.7
33long qt syndrome 510.7
34andersen syndrome10.7
35atrial fibrillation, familial, 610.5
36atrial standstill 210.5
37cardiomyopathy, hypertrophic, 2010.5
38hyperinsulinemic hypoglycemia, familial, 710.5
39atrial fibrillation, familial, 1110.5
40atrial standstill, digenic10.5
41progressive familial heart block, type ii10.5
42cardiomyopathy, hypertrophic, 210.5
43cardiomyopathy, dilated, 1aa, with or without lvnc10.5
44cardiomyopathy, familial hypertrophic, 910.5
45cardiomyopathy, familial hypertrophic10.5
46cardiomyopathy, hypertrophic, 1310.5
47atrial fibrillation, familial, 1010.5
48cardiomyopathy, hypertrophic, 810.5
49cardiomyopathy, hypertrophic, 1610.5
50atrial fibrillation 1510.5

Graphical network of the top 20 diseases related to Syncope:



Diseases related to syncope

Symptoms & Phenotypes for Syncope

About this section

MGI Mouse Phenotypes related to Syncope according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.6KCNH2, KCNJ2, KCNQ1, NPPA, SCN5A

Drugs & Therapeutics for Syncope

About this section

Drugs for Syncope (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 226)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Ranolazineapproved, investigationalPhase 4, Phase 278142387-99-3, 95635-55-556959
Synonyms:
( -)-Ranolazine
(-)-Ranolazine
142387-99-3
95635-55-5
AC-1673
AC1L1M17
AC1Q5LYD
BRD-A97674275-001-01-9
BSPBio_002276
CHEMBL1404
CID56959
CVT-303
D05700
DB00243
HMS1922F16
HMS2090L09
HMS2093D21
I01-2008
I06-0160
KEG-1295
LS-187267
Latixa
Lopac0_001062
 
MLS002154149
MolPort-003-666-653
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
NCGC00015897-05
NCGC00095177-01
NCGC00095177-02
NCGC00095177-03
RAN D
RANOLAZINE
RS-43285
RS-43285-003
Ran4
Ranexa
Ranexa (TN)
Ranexa, Ranolazine
Ranolazine (USAN/INN)
Ranolazine 2HCl
Ranolazine Dihydrochloride
Ranolazine dihydrochloride
S1799_Selleck
SMR000857382
SPECTRUM1505366
UNII-A6IEZ5M406
ranolazine
2
Amiodaroneapproved, investigationalPhase 4, Phase 31201951-25-32157
Synonyms:
(2-Butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diidophenyl)methanone
(2-butyl-1-benzofuran-3-yl)(4-{[2-(diethylamino)ethyl]oxy}-3,5-diiodophenyl)methanone
(2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone
(2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone
(2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone
(2-{4-[(2-butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine
1951-25-3
2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(3,5-diiodo-4-(beta-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(4'-beta-N-diethylaminoethoxy-3',5'-diiodobenzoyl)benzofuran
2-Butyl-3-[3,5-diiodo-4-(2-di
2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-((2-diethylamino)ethoxy)-m,m-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-[(2-diethylamino)ethoxy]-m,m-diiodophenyl ketone
2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
5-18-02-00353 (Beilstein Handbook Reference)
AB00053422
AC1L1D1R
AC1Q2VCU
ASTA Medica Brand of Amiodarone Hydrochloride
Alphapharm Brand of Amiodarone Hydrochloride
Amidorone
Aminodarone
Amio-Aqueous IV
Amiobeta
Amiodarex
Amiodarona
Amiodarona [INN-Spanish]
Amiodarone
Amiodarone (USAN/INN)
Amiodarone Base
Amiodarone HCL
Amiodarone Hydrochloride
Amiodarone [USAN:BAN:INN]
Amiodarons
Amiodaronum
Amiodaronum [INN-Latin]
Amiohexal
Amjodaronum
Ancar
Aratac
Armstrong Brand of Amiodarone Hydrochloride
Arycor
BIDD:GT0425
BIDD:PXR0146
BPBio1_000372
BRN 1271711
BSPBio_000338
BSPBio_001574
BSPBio_002580
Berenguer Infale Brand of Amiodarone Hydrochloride
Betapharm Brand of Amiodarone Hydrochloride
Bio1_000026
Bio1_000515
Bio1_001004
Bio2_000294
Bio2_000774
Braxan
C06823
C25H29I2NO3
CAS-19774-82-4
CBiol_001740
CHEBI:2663
CHEMBL633
CID2157
Corbionax
Cordarex
Cordarone
Cordarone Intravenous
D000638
D02910
DB01118
DivK1c_000079
EINECS 217-772-1
 
G Gam Brand of Amiodarone Hydrochloride
HMS1791O16
HMS1989O16
HMS2089C07
Hexal Brand of Amiodarone Hydrochloride
IDI1_000079
IDI1_034044
KBio1_000079
KBio2_000294
KBio2_000741
KBio2_002862
KBio2_003309
KBio2_005430
KBio2_005877
KBio3_000587
KBio3_000588
KBio3_001800
KBioGR_000294
KBioGR_001859
KBioSS_000294
KBioSS_000741
Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl
Ketone, 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl (7CI,8CI)
Kordaron
L 3428
L-3428
L001174
L3428
LS-87088
Labaz
Leurquin Brand of Amiodarone Hydrochloride
Lopac-A-8423
Lopac0_000122
MolPort-003-703-670
NCGC00015096-01
NCGC00015096-02
NCGC00015096-03
NCGC00015096-10
NCGC00024242-03
NCGC00024242-04
NCGC00024242-05
NCGC00024242-06
NCI60_041885
NINDS_000079
Ortacrone
Pacerone
Pharma Investi Brand of Amiodarone Hydrochloride
Prestwick0_000409
Prestwick1_000409
Prestwick2_000409
Prestwick3_000409
QTL1_000008
Rytmarone
SKF 33134-A
SKF 33134A
SPBio_001825
SPBio_002277
STK529812
STOCK1S-12240
Sanofi Winthrop Brand of Amiodarone Hydrochloride
Sedacoron
Sedacorone
Spectrum2_001813
Spectrum3_001050
Spectrum4_001190
Spectrum5_001533
Spectrum_000261
Tachydaron
UNII-N3RQ532IUT
UNM000001215003
Wyeth Brand of Amiodarone Hydrochloride
amiodarone
ethylaminoethoxy)benzoyl]benzofuran
nchembio.79-comp9
nchembio732-comp1
on
pms-Amiodarone
3
Metoprololapproved, investigationalPhase 420137350-58-6, 51384-51-14171
Synonyms:
(+/-)-Metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
37350-58-6
51384-51-1
54163-88-1
AB00053499
AC-19022
AC1L1HKM
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
BRD-A03623303-045-02-0
Beatrolol
Beloc
Beloc Duriles
Beloc-Duriles
BelocDuriles
Betaloc
Betaloc Astra
Betaloc-Astra
BetalocAstra
Betalok
C07202
CCRIS 4198
CGP 2175
CGP-2175
CGP2175
CHEBI:6904
CHEMBL13
CID4171
D008790
D02358
DB00264
DL-metoprolol
Dl-Metoprolol
Dutoprol
EINECS 253-483-7
EINECS 257-166-4
H 93 26
H 93-26
H 9326
 
HMS2090B15
HSDB 6531
I01-7125
I06-0125
Jsp006606
L000669
LOPRESSIDONE
LS-122450
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
Lopressor
Lopressor HCT
Meijoprolol
Metohexal
Metoprolol
Metoprolol (USAN/INN)
Metoprolol Tartrate
Metoprolol [USAN:INN:BAN]
Metoprolol slow release
Metoprolol succinate
Metoprolol tartrate
Metoprololum
Metoprololum [INN-Latin]
Metroprolol
MolPort-005-938-039
NCGC00021148-02
NCGC00021148-03
NCGC00021148-04
Novartis Brand of Metprolol Tartrate
Preblok
Prelis
Presolol
Selo-Zok
Seloken
Seloken AstraZeneca Brand
Selopral
Seroken
Spesicor
Spesikor
TOPROL-XL
Tartrate, Metoprolol
Toprol
Toprol XL
Toprol-XL
UNII-GEB06NHM23
dl-Metoprolol
metoprolol
4
Hydrochlorothiazideapproved, vet_approvedPhase 4, Phase 340558-93-53639
Synonyms:
125727-50-6
3,4-Dihydro-6-chloro-7-sulfamyl-1,2, 4-benzothi
3,4-Dihydrochlorothiazide
58-93-5
6-Chloro-7-sulfamoyl-3, 4-dihy
8049-49-8
AB00052012
AC-11072
AC1L1GDT
AC1Q55FM
AF-614/30832002
AKOS000121373
ARONIS24316
Acesistem
Acuilix
Acuretic
Aldactazide
Aldactazide 25/25
Aldazida
Aldectazide 50/50
Aldoril
Ambap58-93-5
Apo-Hydro
Apresazide
Aquarills
Aquarius
Aquazide H
Aquazide-H
BAS 00371709
BIDD:GT0153
BPBio1_000019
BRD-K13078532-001-05-2
BRN 0625101
BSPBio_000017
BSPBio_002132
Bio-0714
Bremil
Briazide
C7H8ClN3O4S2
CAS-58-93-5
CCRIS 2082
CHEMBL435
CID3639
CPD000035778
Caplaril
Capozide
Carozide
Catiazida
Chlorizide
Chlorosulthiadil
Chlorothiazide
Chlorsulfonamidodihydrobenzothiadiazine dioxide
Chlorzide
Chlothia
Cidrex
Clorana
Component of Butizide Prestabs
Concor Plus
Condiuren
D00340
D006852
DB00999
Diaqua
Dichlorosal
Dichlorotride
Dichlothiazide
Dichlotiazid
Dichlotride
Diclotride
Dicyclotride
Didral
Dihydran
Dihydrochlorothiazid
Dihydrochlorothiazide
Dihydrochlorothiazidum
Dihydrochlorurit
Dihydrochlorurite
Dihydroxychlorothiazidum
Direma
Disalunil
Disothiazid
Diu 25 Vigt
Diu-Melusin
Diu-melusin
Diuril
Diurogen
DivK1c_000289
Dixidrasi
Drenol
Dyazide
EINECS 200-403-3
EU-0100614
Esidrex
Esidrix
Esidrix (TN)
Esimil
Esoidrina
FT-0082750
Fluvin
H 4759
H1274
H2910_SIAL
H4759_SIAL
HCT
HCT-Isis
HCTZ
HCZ
HMS1568A19
HMS1920D19
HMS2091L05
HMS500O11
HMS553N04
HSDB 3096
Hidril
Hidro-Niagrin
Hidrochlortiazid
Hidroclorotiazida
Hidroclorotiazida [INN-Spanish]
Hidroronol
Hidrosaluretil
Hidrotiazida
Hyclosid
Hydrex-semi
Hydril
Hydro Par
Hydro-Aquil
Hydro-D
Hydro-Diuril
Hydro-Saluric
Hydro-T
Hydro-chlor
HydroDIURIL
Hydrochlorat
Hydrochloro Thiazide
Hydrochlorot
Hydrochlorothiazid
Hydrochlorothiazide
Hydrochlorothiazide (JP15/USP/INN)
Hydrochlorothiazide Intensol
Hydrochlorothiazide [INN:BAN:JAN]
 
Hydrochlorothiazidum
Hydrochlorothiazidum [INN-Latin]
Hydrochlorthiazide
Hydrochlorthiazidum
Hydrocot
Hydrodiuretic
Hydrodiuril
Hydropres
Hydrosaluric
Hydrothide
Hydrozide
Hydrozide Injection, Veterinary
Hypothiazid
Hypothiazide
Hytrid
Hyzaar
I09-0531
IDI1_000289
Idroclorotiazide
Idroclorotiazide [DCIT]
Idrotiazide
Inderide
Inderide 80/25
Indroclor
Ivaugan
Jen-Diril
KBio1_000289
KBio2_001357
KBio2_003925
KBio2_006493
KBio3_001352
KBioGR_000351
KBioSS_001357
LS-243
Lopac-H-4759
Lopac0_000614
Lopressor HCT
Lotensin HCT
Lotensin Hct
MLS000069619
Manuril
Maschitt
Maxzide
Maybridge Compound 10
Maybridge1_004336
Mazide 25 mg
Medozide
Megadiuril
Microzide
Microzide (TN)
Mictrin
Mikorten
Modurcen
Moduretic
MolPort-000-144-465
NCGC00015508-01
NCGC00015508-02
NCGC00015508-03
NCGC00015508-07
NCGC00015508-12
NCGC00021906-03
NCGC00021906-04
NCGC00021906-05
NCGC00021906-06
NCGC00021906-07
NCGC00021906-08
NCI-C55925
NCI60_004317
NINDS_000289
NSC 53477
NSC53477
Natrinax
Nefrix
Nefrol
Neo-Codema
Neo-Flumen
Neo-Minzil
Neo-codema
Neoflumen
Newtolide
Novodiurex
Oprea1_357174
Oretic
Pantemon
Panurin
Prestwick0_000009
Prestwick1_000009
Prestwick2_000009
Prestwick3_000009
Prestwick_263
Prinzide
Raunova Plus
Ro-Hydrazide
Ro-hydrazide
Roxane
S1708_Selleck
SAM002554901
SMR000035778
SPBio_001259
SPBio_001938
SPECTRUM1500335
STK315354
Saldiuril
Sectrazide
Selozide
Ser-Ap-Es
Servithiazid
Spectrum2_001040
Spectrum3_000456
Spectrum4_000006
Spectrum5_000824
Spectrum_000877
Spironazide
Su 5879
Tandiur
Thiaretic
Thiuretic
Thlaretic
Timolide
UNII-0J48LPH2TH
Unazid
Unipres
Urodiazin
Urozide
Vaseretic
Vetidrex
WLN: T66 BSWM EM DHJ HG ISZW
ZINC00896569
Ziac
Zide
adiazine-1,1-dioxide
component of Aldactazide
component of Aldoril
component of Caplaril
component of Cyclex
component of Dyazide
component of Esimil
diclot ride
dro-2H-1,2,4-benzothiadiazine 1,1-dioxide
hydrochlorothiazide
panurin dichloride
5
FludrocortisoneapprovedPhase 426127-31-131378
Synonyms:
(11beta)-9-Fluoro-11,17,21-trihydroxypregn-4-ene-3,20-dione
(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
127-31-1
4-08-00-03427 (Beilstein Handbook Reference)
9 .alpha. FF
9 Fluoro 17 Hydroxycortisone
9 Fluorocortisol
9 Fluorohydrocortisone
9 alpha FF
9 alpha Fludrohydrocortisone
9 alpha Fluoro 17 Hydroxycorticosterone
9 alpha Fluorohydrocortisone
9 alpha-Fludrocortisone
9 alpha-Fluoro-17-Hydroxycorticosterone
9 alpha-Fluorocortisol
9 alpha-Fluorohydrocortisone
9-AF
9-AFH
9-Fluoro-11-beta,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-17-Hydroxycortisone
9-Fluorocortisol
9-Fluorohydrocortisone
9-alpha-Fludrocortisone
9-alpha-Fluoro-17-hydroxycorticosterone
9-alpha-Fluorocortisol
9-alpha-Fluorohydrocortisone
9.alpha.-Fluoro-11.beta.,17.alpha.,21-trihydroxy-4-pregnene-3,20-dione
9.alpha.-Fluoro-17-hydroxycorticosterone
9.alpha.-Fluorocortisol
9.alpha.-Fluorohydrocortisone
9alpha-FLUOROCORTISOL
9alpha-Fludrocortisone
9alpha-Fluoro-11beta,17alpha,21-trihydroxy-4-pregnene-3,20-dione
9alpha-Fluoro-17-hydroxycorticosterone
9alpha-Fluoro-hydrocortisone
9alpha-Fluorocortisol
AC1L1LI8
AC1Q5HJH
Alflorone
Astonin
Astonin H
Astonin Merck
Astonin-H
Astonin-H (TN)
BRN 3014278
 
C07004
C21H29FO5
CHEBI:50885
CHEMBL1201388
CID31378
D005438
D07967
DB00687
DB02478
EINECS 204-833-2
F-COL
F-Cortef
FCOL
Florinef
Fludrocortison
Fludrocortisona
Fludrocortisona [INN-Spanish]
Fludrocortisone
Fludrocortisone (INN)
Fludrocortisone [INN:BAN]
Fludrocortisonum
Fludrocortisonum [INN-Latin]
Fludrocortone
Fludrone
Fludronef
Fluodrocortisone
Fluohydrisone
Fluohydrocortisone
Fluorocortisol
Fluorocortisone
HSDB 3332
Hydrocortisone-9alpha-fluoro
LMST02030103
LS-118690
Merck Brand of Fludrocortisone
Merck, Astonin
MolPort-005-943-437
NCGC00181081-01
NSC 11318
NSC11318
Pregn-4-ene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy- (8CI)
Prestwick_648
StC 1400
U 5963
UNII-U0476M545B
WLN: L E5 B666 OV MUTJ A1 BF CQ E1 FV1Q FQ
ZINC04097304
ZK5
fludrocortisone
6
Treprostinilapproved, investigationalPhase 48581846-19-754786, 6918140
Synonyms:
((1R,2R,3aS,9aS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate
(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid
({(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl}oxy)acetic acid
15 AU81
15AU81
2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
2-[[(1S,2S,3aR,9aR)-2-hydroxy-1-[(3R)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
289480-64-4 (Sodium salt)
81846-19-7
AC1L1HPX
AC1OCF2J
CHEBI:50861
CID11246284
CID54786
CID6918140
CID9800580
D06213
DB00374
L001079
 
LRX 15
LS-177654
LS-187014
LS-187645
Remodulin (TN)
Treprostinil
Treprostinil (USAN/INN)
Treprostinil [USAN:INN]
Treprostinil sodium
Treprostinilo
Treprostinilum
U 62840
U-62,840
UNII-RUM6K67ESG
UT-15
Uniprost
Viveta
[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid
treprostinilo
treprostinilum
7
Propranololapproved, investigationalPhase 4, Phase 2216525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
8
MidodrineapprovedPhase 444133163-28-7, 42794-76-34195
Synonyms:
( -)-Midodrin hydrochloride
( -)-Midodrine hydrochloride
()-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol
(+-)-1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide monohydrochloride
(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide
(+-)-Midodrine hydrochloride
(+/-)-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol
(RS)-N'-(beta-Hydroxy-2,5-dimethoxy-phenethyl)glycinamid
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamid
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethylacetamide
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide monohydrochloride
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide monohydrochloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide hydrochloride
3092-17-9
3092-17-9 (mono-hydrochloride)
42794-76-3
42794-76-3 (Parent)
43218-56-0
97476-58-9
A 4020 Linz
A-4020 Linz
AB00053715
AC1L1HMJ
AC1L2BU9
Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride
Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, hydrochloride
Alphamine
Amatine
BPBio1_000157
BRD-A79981887-003-05-7
BSPBio_000141
BSPBio_003150
C07890
C12H18N2O4
C12H18N2O4.HCl
CHEBI:31847
CHEBI:6933
CHEMBL1200461
CID18340
CID4195
CPD000058833
D01307
D08220
DB00211
DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid
DivK1c_000955
EINECS 255-945-3
EINECS 256-148-3
Gutron
HMS1568H03
HMS1922O03
Hipertan
I06-0865
IDI1_000955
KBio1_000955
KBio2_002121
KBio2_004689
KBio2_007257
 
KBio3_002650
KBioGR_000763
KBioSS_002121
LS-174957
LS-8042
LS-8052
M8277_FLUKA
M8277_SIGMA
MIDODRINE HYDROCHLORIDE
MLS001332567
MLS001332568
MLS002154233
Metligene
Midamine
Midodrin
Midodrina
Midodrina [INN-Spanish]
Midodrine (INN)
Midodrine HCL
Midodrine Monohydrochloride
Midodrine [BAN:INN]
Midodrine [INN:BAN]
Midodrine hydrochloride
Midodrine hydrochloride (JAN/USAN)
Midodrine hydrochloride [USAN:JAN]
Midodrine hydrochloride [USAN]
Midodrinum
Midodrinum [INN-Latin]
MolPort-003-666-473
MolPort-003-849-221
N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide
N-{2-[2,5-bis(methyloxy)phenyl]-2-hydroxyethyl}glycinamide
NCGC00095311-01
NCGC00178238-01
NCGC00178238-02
NINDS_000955
Prestwick0_000191
Prestwick1_000191
Prestwick2_000191
Prestwick3_000191
Prestwick_625
Pro-Amatine
Pro-Amatine (TN)
ProAmatine
SAM002564219
SBB066174
SMR000058833
SPBio_001390
SPBio_002062
SPECTRUM1503257
ST-1085
Spectrum2_001545
Spectrum3_001585
Spectrum4_000192
Spectrum5_000962
Spectrum_001641
St 1085
St. Peter 224
TL8002369
TS 701
UNII-59JV96YTXV
UNII-6YE7PBM15H
[+/-]-1-[2,5-Dimethoxyphenyl]-2-glycinamidoethanol
midodrine
9
EpoprostenolapprovedPhase 45361849-14-7, 35121-78-95280427, 5282411
Synonyms:
(5E)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z)-5-[(4R,5R)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoate
(5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate
(5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13E,15S)-11,15-dihydroxy-6,9-epoxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(Z)-(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valeric acid
136626-78-3
35121-78-9
5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
5-[5-hydroxy-4-(3-hydroxyoct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
6,9-alpha-Epoxy-11-alpha,15(S)-dihydroxyprosta-5(Z),13(E)-dien-1-oic acid
61849-14-7
63748-50-5
63859-31-4
AC1L18LX
AC1L3FZB
AC1NQX0K
AC1NR00P
AC1O51WG
AC1O5HI7
AR-1I7150
BIDD:GT0514
BRD-K64054020-001-02-7
BRN 1690090
BSPBio_001496
Bio2_000216
Bio2_000696
C01312
CHEBI:15552
CHEMBL1139
CHEMBL307845
CID114805
CID11969614
CID159
CID5280427
CID5282411
CID6434194
CID6450541
 
CID9864371
CID9975312
D00106
DB01240
Epoprostanol
Epoprostenol
Epoprostenol (TN)
Epoprostenol (USAN/INN)
Epoprostenol [USAN:INN]
Epoprostenolum
Epoprostenolum [INN-Latin]
Flolan
HMS1791K18
HMS1989K18
IDI1_033966
KB-IV-24
KBio2_000216
KBio2_002784
KBio2_005352
KBio3_000431
KBio3_000432
KBioGR_000216
KBioSS_000216
LMFA03010087
LS-125828
NCGC00161285-01
NCGC00161285-02
NCGC00161285-03
PDSP1_001721
PDSP2_001704
PG-I2
PGI(sub 2)
PGI2
PGX
Prostacyclin
Prostacyclin I2
Prostacycline
Prostacyclins
Prostaglandin I
Prostaglandin I(2)
Prostaglandin I2
Prostaglandin X
Prostaglandin x
Prostaglandins X
SMP2_000227
TRY 200
Try-200
U 53,217
U-53217
UNII-DCR9Z582X0
Vasocyclin
epoprostenol
prostacyclin
prostaglandin I2
10
AmlodipineapprovedPhase 448688150-42-92162
Synonyms:
()-Amlodipine
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)
3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
88150-42-9
88150-47-4 (maleate (1:1))
AC-4535
AC1L1D26
AC1Q32ZS
AMLODIPINE BASE
AMVAZ
Ambap88150-42-9
Amlocard
Amlodipine
Amlodipine (INN)
Amlodipine Benzenesulfonate
Amlodipine Besilate
Amlodipine Besylate
Amlodipine Free Base
Amlodipine [INN:BAN]
Amlodipine besilate
Amlodipine besylate
Amlodipine free base
Amlodipino
Amlodipino [Spanish]
Amlodipinum
Amlodipinum [Latin]
Amlodis
Amlopres
Amlor
 
Amvaz
BIDD:GT0810
BRD-A22032524-074-02-4
BRD-A22032524-074-03-2
BSPBio_002727
C06825
CHEBI:2668
CHEMBL1491
CID2162
CPD000469198
Coroval
D07450
DB00381
HMS2052N03
HMS2089H07
I14-0798
Intervask
Istin
KBio3_001947
KBioGR_001643
LS-131183
Lipinox
Lotrel
MLS001401409
MolPort-001-792-963
NCGC00165957-01
NCGC00165957-02
NCGC00165957-03
Norvasc
Norvasc (TN)
Pelmec
R,S)-Amlodipine
Racemic Amlodipine
SAM001246705
SMR000469198
SPBio_000351
Spectrum2_000486
Spectrum3_001004
Spectrum4_001132
Spectrum5_001550
UK-4834011
UNII-1J444QC288
amlodipine
11
LosartanapprovedPhase 4282114798-26-43961
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DUP 89
DuP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
 
KBio2_004761
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
LOSARTAN POTASSIUM
LS-78746
Lacidipine
Lortaan
Losartan
Losartan (INN)
Losartan Potassium
Losartan [INN:BAN]
Losartan monopotassium salt
Losartic
Losartic (TN)
MK-954
MK954
MolPort-003-666-553
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
SPBio_001893
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
Spectrum_001713
UNII-JMS50MPO89
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
losartan
losartan potassium
12Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 122776
13Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 117734
14Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 15140
15Adrenergic AntagonistsPhase 4, Phase 3, Phase 21535
16Cytochrome P-450 CYP2D6 InhibitorsPhase 4, Phase 3716
17Cytochrome P-450 CYP2C9 InhibitorsPhase 4, Phase 3658
18Cytochrome P-450 CYP1A2 InhibitorsPhase 4, Phase 3553
19Anti-Arrhythmia AgentsPhase 4, Phase 3, Phase 22969
20Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 33822
21Cytochrome P-450 CYP3A InhibitorsPhase 4, Phase 31666
22Sodium Channel BlockersPhase 4, Phase 3, Phase 21515
23Vasodilator AgentsPhase 4, Phase 3, Phase 23438
24Diuretics, Potassium SparingPhase 4, Phase 3, Phase 21827
25Potassium Channel BlockersPhase 4, Phase 3176
26diureticsPhase 4, Phase 3, Phase 1, Phase 21372
27
Angiotensin IIPhase 4, Phase 3116268521-88-0, 11128-99-7172198, 65143
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
28Angiotensin II Type 1 Receptor BlockersPhase 4, Phase 31078
29Natriuretic AgentsPhase 4, Phase 3, Phase 1, Phase 21645
30VaccinesPhase 4, Phase 26428
31Angiotensin Receptor AntagonistsPhase 4, Phase 31173
32AngiotensinogenPhase 4, Phase 31161
33Adrenergic alpha-AgonistsPhase 4, Phase 1, Phase 2, Early Phase 11625
34Adrenergic AgonistsPhase 4, Phase 1, Phase 2, Early Phase 12877
35Antihypertensive AgentsPhase 4, Phase 3, Phase 24095
36Adrenergic beta-AntagonistsPhase 4, Phase 3, Phase 2, Phase 11154
37Anti-Inflammatory AgentsPhase 4, Phase 1, Phase 210355
38Sodium Chloride Symporter InhibitorsPhase 4, Phase 3446
39Autonomic AgentsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 19774
40Adrenergic beta-1 Receptor AntagonistsPhase 4, Phase 3350
41TezosentanPhase 465
42Vasoconstrictor AgentsPhase 4, Phase 1, Phase 2, Early Phase 12027
43SympatholyticsPhase 4, Phase 3555
44Calcium, DietaryPhase 4, Phase 35525
45calcium channel blockersPhase 41940
46Platelet Aggregation InhibitorsPhase 42419
47
Icodextrinapproved, investigationalPhase 337337376-15-5
Synonyms:
Icodextrin
 
Icodextrina
Icodextrine
Icodextrinum
48
Adenosineapproved, investigationalPhase 339758-61-760961
Synonyms:
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose
1odi
2fqy
2gl0
30143-02-3
4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside
46946-45-6
46969-16-8
58-61-7
6-Amino-9-.beta.-ribofuranosyl-9H-purine
6-Amino-9-beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-delta-ribofuranosyl-9H-purine
9-(beta-D-Arabinofuranosyl)adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-Ribofuranosidoadenine
9-beta-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Ribofuranosyladenine
9-beta-delta-Arabinofuranosyladenine
9-beta-delta-Ribofuranosidoadenine
9-beta-delta-Ribofuranosyl-9H-purin-6-amine
9-beta-delta-Ribofuranosyladenine
9beta-D-Ribofuranosyladenine
9beta-D-ribofuranosyl-9H-Purin-6-amine
9beta-delta-Ribofuranosyladenine
9beta-delta-ribofuranosyl-9H-Purin-6-amine
A0152
A4036_SIGMA
A9251_SIGMA
AC1L1U8O
AC1Q1ID3
AC1Q52XU
ADN
AI3-52413
Ade-Rib
Ade-rib
Adenin riboside
Adenine 9-beta-D-arabinofuranoside
Adenine deoxyribonucleoside
Adenine nucleoside
Adenine riboside
Adenine-9-beta-D-ribofuranoside
Adenine-9beta-D-Ribofuranoside
Adenine-9beta-delta-Ribofuranoside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosina
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine, homopolymer
Adenosinum
Adensoine
Adenyldeoxyriboside
Ado
Adénosine
BB_NC-0565
BSPBio_001796
Bio1_000437
 
Bio1_000926
Bio1_001415
Boniton
C00212
CCRIS 2557
CHEBI:16335
CHEMBL477
CID60961
Caswell No. 010B
D000241
D00045
DB00640
Deoxyadenosine
Desoxyadenosine
EA6C60C2-6AFB-4264-A2F0-541373DB950E
EINECS 200-389-9
FT-0082881
HMS1920A13
HMS2091G13
KBio3_001296
LS-15085
MEDR-640
MLS000069638
MLS002153227
MolPort-001-838-229
Myocol
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NSC 627048
NSC 7652
NSC627048
NSC7652
Nucleocardyl
Pallacor
Polyadenosine
Polyriboadenosine
S1647_Selleck
SDCCGMLS-0003108.P003
SMR000058216
SPBio_001194
SPECTRUM1500107
SR 96225
SR-96225
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum3_000288
TL8003749
UNII-K72T3FS567
USAF CB-10
V0098
Vidarabine
ZINC02169830
adenine-D-ribose
adenosine
b-D-Adenosine
beta-Adenosine
beta-D-Adenosine
beta-D-Ribofuranoside, adenine-9
beta-delta-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.2007.56-comp13
nchembio.64-comp4
nchembio706-5
49
LactuloseapprovedPhase 3944618-18-211333
Synonyms:
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
4-O-b-D-Galactopyranosyl-D-Fructofuranose
4-O-b-D-Galactopyranosyl-D-fructose
4-O-beta-D-Galactopyranosyl-D-Fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructose
4-O-beta-delta-Galactopyranosyl-delta-Fructofuranose
4-O-beta-delta-Galactopyranosyl-delta-fructose
 
Bifiteral
Cephulac
D-Lactulose
Lactulosa
Lactulose
Lactulosum
delta-Lactulose
lactulosa
lactulosum
50
Mannitolapproved, investigationalPhase 326869-65-8453, 6251
Synonyms:
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
AR-1J3861
Ambap69-65-8
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-Mannitol
D-Mannitol (JP15)
D-mannite
D-mannitol
D00062
D008353
DL-Mannitol
Diosmol
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Fraxinine
HSDB 714
Hexahydroxyhexane
Hexanhexol
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
M9546_SIAL
M9647_SIAL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
 
MANNITOL 25%
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
MLS001335977
MLS001335978
MTL
Manicol
Manitol
Maniton S
Maniton-S
Manna Sugar
Manna sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol 10%
Mannitol 10% In Plastic Container
Mannitol 15%
Mannitol 15% In Plastic Container
Mannitol 20%
Mannitol 20% In Plastic Container
Mannitol 5%
Mannitol 5% In Plastic Container
Mannitol [USAN]
Mannitolum
Mannogem 2080
Marine Crystal
Marine crystal
MolPort-003-927-039
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
Osmitrol 15% In Water
Osmitrol 20% In Water
Osmitrol 5% In Water
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
SORBITOL-MANNITOL IN PLASTIC CONTAINER
Sorbitol-Mannitol
TL806434
UNII-3OWL53L36A
ZINC02041302
bmse000099
cpd without stereochemical designation
e 421
e-421
e421
manita
mannitol

Interventional clinical trials:

(show top 50)    (show all 271)
idNameStatusNCT IDPhase
1Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study)Unknown statusNCT01621464Phase 4
2Safety of Amiodarone and Ranolazine Together in Patients With AnginaUnknown statusNCT01558830Phase 4
3ISSUE3: International Study on Syncope of Uncertain Etiology 3CompletedNCT00359203Phase 4
4Clinical Trial for the Prevention of Vasovagal SyncopeCompletedNCT00118482Phase 4
5ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic SyncopeCompletedNCT00170261Phase 4
6Propranolol to Treat Fainting Due to Sympathoadrenal ImbalanceCompletedNCT00060866Phase 4
7Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCompletedNCT01518946Phase 4
8Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate TherapyCompletedNCT00947310Phase 4
9Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention IndicationCompletedNCT00743522Phase 4
10Physiologic Evaluation of Anomalous Right Coronary Artery StenosisCompletedNCT01133054Phase 4
11A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy SitesCompletedNCT01722994Phase 4
12Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to RemodulinCompletedNCT00373360Phase 4
13Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IVRecruitingNCT01456481Phase 4
14Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging SubjectsRecruitingNCT02123056Phase 4
15Comparision of Blood Pressure Variability Between Amlodipine and LosartanRecruitingNCT01964079Phase 4
16Evaluation of PCLs Using Three EUS-FNA NeedlesRecruitingNCT01711294Phase 4
17Syncope: Pacing or Recording in the Later YearsActive, not recruitingNCT01423994Phase 4
18Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)Active, not recruitingNCT01567813Phase 4
19International Study on Syncope of Uncertain EtiologyTerminatedNCT00120094Phase 4
20A Phase IV Study in Subjects With Neurogenic Orthostatic HypotensionTerminatedNCT00046163Phase 4
21Rapid Switch From Flolan to Remodulin in the Outpatient ClinicTerminatedNCT00643604Phase 4
22Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAHTerminatedNCT00439946Phase 4
23Adenosine Testing to DEtermine the Need for Pacing TherapyUnknown statusNCT01481168Phase 3
24Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in ChildrenUnknown statusNCT01587846Phase 3
25Stop Vasodepressor Drugs in Reflex SyncopeCompletedNCT02137278Phase 3
26A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseCompletedNCT01176240Phase 3
27Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionCompletedNCT00095550Phase 3
28Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionCompletedNCT00095394Phase 3
29Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00633880Phase 3
30Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT AblationCompletedNCT01045668Phase 3
31Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSDCompletedNCT00532493Phase 3
32Induction With Foley OR Misoprostol (INFORM) StudyCompletedNCT01801410Phase 3
33Chagas Cardiomyopathy Bisoprolol Intervention Study: CharityCompletedNCT00323973Phase 3
34Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of LaborCompletedNCT00308711Phase 3
35A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaCompletedNCT00782340Phase 3
36Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00738062Phase 3
37Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory SyncopeRecruitingNCT01814228Phase 3
38The IPED (Investigation of Palpitations in the ED) StudyRecruitingNCT02783898Phase 3
39Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.RecruitingNCT02809131Phase 3
40Efficacy of Implantable Defibrillator Therapy After a Myocardial InfarctionRecruitingNCT00673842Phase 3
41Effects of PTH Replacement on Bone in HypoparathyroidismActive, not recruitingNCT00395538Phase 3
42Ballooned Intercostal Drain TrialNot yet recruitingNCT03000504Phase 3
43Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained SyncopeTerminatedNCT00143754Phase 3
44A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyTerminatedNCT01927055Phase 3
45Hydroquinidine Versus Placebo in Patients With Brugada SyndromeTerminatedNCT00927732Phase 3
46Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.WithdrawnNCT02004626Phase 3
47Trial Comparing Ablation With Medical Therapy in Patients With Ventricular TachycardiaWithdrawnNCT01798277Phase 3
48Non-Pharmacologic Therapy for Neurocardiogenic SyncopeCompletedNCT00096902Phase 2
49Propranolol to Treat Fainting in Children With Sympathoadrenal ImbalanceCompletedNCT00093860Phase 2
50Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood DonationsCompletedNCT00302900Phase 2

Search NIH Clinical Center for Syncope

Genetic Tests for Syncope

About this section

Genetic tests related to Syncope:

id Genetic test Affiliating Genes
1 Syncope27

Anatomical Context for Syncope

About this section

MalaCards organs/tissues related to Syncope:

36
Testes, Brain, Heart, Thyroid, Liver, Bone, Skin

Publications for Syncope

About this section

Articles related to Syncope:

(show top 50)    (show all 883)
idTitleAuthorsYear
1
Accessory Liver in the Right Atrium: A Rare Cause of Syncope. (27549551)
2016
2
Type I Chiari malformation presenting orthostatic syncope who treated with decompressive surgery. (28018469)
2016
3
Syncope on a Hot Summer Day. (27131612)
2016
4
Syncope in older adults. (27594863)
2016
5
The Current Indication for Pacemaker in Patients with Cardioinhibitory Vasovagal Syncope. (27651841)
2016
6
Heartbeat: Detection of arrhythmias in older adults with falls and syncope. (27073247)
2016
7
Chronic Myeloid Leukemia: A Case of Extreme Thrombocytosis Causing Syncope and Myocardial Infarction. (27004153)
2016
8
Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy. (26847485)
2016
9
Searching for the cause of syncope: non-sustained ventricular tachycardia or neurocardiogenic syndrome. Does it really need lengthy investigation? (27098073)
2016
10
Syncope With Profound Bradycardia. (27134236)
2016
11
Long-Term Outcome of Patients with Bifascicular Block and Unexplained Syncope Following Cardiac Pacing. (27565449)
2016
12
Syncope in a 62-year-old man with sarcoidosis. (27131072)
2016
13
Thrombosis of Inferior Vena Cava Diagnosed Using Point-of-Care Ultrasound After Pediatric Near-Syncope. (27545854)
2016
14
Pathophysiological mechanisms of noncardiac syncope in athletes. (27606909)
2016
15
Opportunities for Emergency Medical Services (EMS) Care of Syncope. (27211803)
2016
16
Straight Back Syndrome Masquerading as a Mass, with Near-Syncope. (27127446)
2016
17
Syncope (Fainting). (27142609)
2016
18
An atypical cause of malignant syncope and sudden cardiac arrest. (27165629)
2016
19
Beta 3 subunit of G-protein and its influence on autonomic nervous system in patients with vasovagal syncope. (26925743)
2016
20
Management of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia and Vasovagal Syncope. (27617091)
2016
21
Theophylline and syncope. (27537745)
2016
22
Intracardiac Leiomyomatosis - an Unusual Cause of Syncope in a Middle-Aged Woman. (27743856)
2016
23
Short term prognosis and current management of syncopal patients at intermediate-risk. Results from the IRiS (Intermediate-Risk Syncope) Study. (27178670)
2016
24
Differential effects of ganglionic plexi ablation in a patient with neurally mediated syncope and intermittent atrioventricular block: a commentary. (27302390)
2016
25
A Male Patient with Syncope, Anaphylaxis, and ST-Elevation: Hepatic and Cardiac Echinococcosis Presenting with Kounis Syndrome. (27516403)
2016
26
Post-exercise syncope: Wingate syncope test and visual-cognitive function. (27550986)
2016
27
Stop vasodepressor drugs in reflex syncope: a randomised controlled trial. (27664002)
2016
28
Reduced compensatory responses to maintain central blood volume during hypovolemic stress in women with vasovagal syncope. (27654398)
2016
29
Syncope: Not for the faint hearted. (27189260)
2016
30
The mechanism of syncope without prodromes with normal heart and normal electrocardiogram. (27639455)
2016
31
Recurrent Syncope: An Unusual Complication of Hypertensive Heart Disease. (27448490)
2016
32
Case 4 - A 67 Year-Old Man with Aortic Regurgitation Who Presented Syncope Followed by Shock. (27627642)
2016
33
Syncope in patients paced for atrioventricular block. (26851815)
2016
34
The Evaluation of Syncope in a Predominantly Black Population: Focus on Neuroimaging. (27583235)
2016
35
Genome-Wide Association Study of Copy Number Variations in Patients with Familial Neurocardiogenic Syncope. (27156083)
2016
36
The Cost-Effective Evaluation of Syncope. (27542422)
2016
37
Early onset brain calcifications secondary to hypoparathyroidism in a boy with syncopal-like symptomatology. (27909973)
2016
38
From syncope episode to the diagnosis of ovarian dermoid cyst associated with a cystadenoma. (26968295)
2016
39
Syncope Following Orthotopic Heart Transplant: Sinoatrial or Atrioventricular Nodal Block? (27214093)
2016
40
Syncope and sudden cardiac death: some answers to clinical challenges. (27190173)
2016
41
77-year-old female with syncope. (27664004)
2016
42
Glossopharyngeal neuralgia associated with cardiac syncope. (27102416)
2016
43
Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. (27092427)
2016
44
The circadian rhythm of syncopal episodes in patients with neurally mediated syncope. (27128529)
2016
45
Primary Cardiac Sarcoidosis with Syncope and Refractory Atrial Arrhythmia: A Case Report and Review of the Literature. (27303240)
2016
46
An Experimental Model of Vasovagal Syncope Induces Cerebral Hypoperfusion and Fainting-Like Behavior in Awake Rats. (27658057)
2016
47
Assessment of endothelin and copeptin as biomarkers for vasovagal syncope. (26641207)
2016
48
Inflammatory myofibroblastic tumor of carotid artery resulting in recurrent syncope: A case report. (27028414)
2016
49
Syncope and collapse in acute pulmonary embolism. (27107684)
2016
50
A rare cause of syncope in a young female. (27567040)
2016

Variations for Syncope

About this section

Expression for genes affiliated with Syncope

About this section
Search GEO for disease gene expression data for Syncope.

Pathways for genes affiliated with Syncope

About this section

Pathways related to Syncope according to GeneCards Suite gene sharing:

(show top 50)    (show all 72)
idSuper pathwaysScoreTop Affiliating Genes
19.0KCNH2, KCNJ2, KCNQ1, SCN5A
28.9GNB3, KCNH2, KCNQ1, SCN5A
3
Show member pathways
8.8GNB3, KCNH2, KCNJ2, KCNQ1
4
Show member pathways
8.5CALM1, CALM2, CALM3
5
Show member pathways
8.5CALM1, CALM2, CALM3
68.5CALM1, CALM2, CALM3
7
Show member pathways
8.5CALM1, CALM2, CALM3
88.5CALM1, CALM2, CALM3
9
Show member pathways
8.5CALM1, CALM2, CALM3
108.5CALM1, CALM2, CALM3
118.5CALM1, CALM2, CALM3
128.5CALM1, CALM2, CALM3
138.5CALM1, CALM2, CALM3
14
Show member pathways
8.5CALM1, CALM2, CALM3
15
Show member pathways
8.5CALM1, CALM2, CALM3
168.5CALM1, CALM2, CALM3
17
Show member pathways
8.5CALM1, CALM2, CALM3
18
Show member pathways
8.5CALM1, CALM2, CALM3
19
Show member pathways
8.5CALM1, CALM2, CALM3
20
Show member pathways
8.5CALM1, CALM2, CALM3
21
Show member pathways
8.5CALM1, CALM2, CALM3
22
Show member pathways
8.5CALM1, CALM2, CALM3
23
Show member pathways
8.5CALM1, CALM2, CALM3
24
Show member pathways
8.5CALM1, CALM2, CALM3
258.5CALM1, CALM2, CALM3
26
Show member pathways
8.5CALM1, CALM2, CALM3
27
Show member pathways
8.5CALM1, CALM2, CALM3
288.5CALM1, CALM2, CALM3
298.5CALM1, CALM2, CALM3
30
Show member pathways
8.5CALM1, CALM2, CALM3
31
Show member pathways
8.5CALM1, CALM2, CALM3
32
Show member pathways
8.5CALM1, CALM2, CALM3
338.5CALM1, CALM2, CALM3
348.5CALM1, CALM2, CALM3
358.5CALM1, CALM2, CALM3
368.5CALM1, CALM2, CALM3
378.5CALM1, CALM2, CALM3
388.5CALM1, CALM2, CALM3
398.5CALM1, CALM2, CALM3
408.5CALM1, CALM2, CALM3
418.5CALM1, CALM2, CALM3
428.5CALM1, CALM2, CALM3
438.5CALM1, CALM2, CALM3
448.5CALM1, CALM2, CALM3
458.5CALM1, CALM2, CALM3
468.1CALM1, CALM2, CALM3, NPPA
47
Show member pathways
8.1CALM1, CALM2, CALM3, KCNJ2
488.1CALM1, CALM2, CALM3, KCNJ2
49
Show member pathways
8.0CALM1, CALM2, CALM3, GNB3
50
Show member pathways
8.0CALM1, CALM2, CALM3, GNB3

GO Terms for genes affiliated with Syncope

About this section

Cellular components related to Syncope according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1T-tubuleGO:003031510.2KCNJ2, SCN5A
2calcium channel complexGO:00347049.3CALM1, CALM2, CALM3
3growth coneGO:00304269.3CALM1, CALM2, CALM3
4neuron projectionGO:00430059.3CALM2, CALM3, GNB3, SLC6A2
5sarcomereGO:00300179.2CALM1, CALM2, CALM3
6spindle microtubuleGO:00058769.1CALM1, CALM2, CALM3
7spindle poleGO:00009229.1CALM1, CALM2, CALM3
8vesicleGO:00319829.0CALM1, CALM2, CALM3
9voltage-gated potassium channel complexGO:00080767.4CALM1, CALM2, CALM3, KCNH2, KCNJ2, KCNQ1
10plasma membraneGO:00058866.8CALM1, CALM2, CALM3, GNB3, KCNH2, KCNJ2

Biological processes related to Syncope according to GeneCards Suite gene sharing:

(show top 50)    (show all 56)
idNameGO IDScoreTop Affiliating Genes
1membrane repolarization during ventricular cardiac muscle cell action potentialGO:009891510.5KCNH2, KCNQ1
2potassium ion exportGO:007143510.5KCNH2, KCNQ1
3potassium ion export across plasma membraneGO:009762310.5KCNH2, KCNQ1
4membrane depolarization during action potentialGO:008601010.5KCNH2, SCN5A
5positive regulation of cardiac muscle contractionGO:006045210.4KCNQ1, NPPA
6positive regulation of heart rateGO:001046010.4KCNQ1, NPPA
7cardiac muscle cell action potential involved in contractionGO:008600210.4KCNJ2, SCN5A
8membrane depolarization during cardiac muscle cell action potentialGO:008601210.4KCNJ2, SCN5A
9regulation of cardiac muscle cell contractionGO:008600410.3KCNJ2, SCN5A
10cardiac muscle contractionGO:006004810.2KCNH2, KCNQ1, SCN5A
11membrane repolarization during action potentialGO:008601110.1KCNH2, KCNJ2, KCNQ1
12membrane repolarization during cardiac muscle cell action potentialGO:008601310.1KCNH2, KCNJ2, KCNQ1
13positive regulation of potassium ion transmembrane transportGO:190138110.0KCNH2, KCNJ2, KCNQ1
14regulation of ventricular cardiac muscle cell membrane repolarizationGO:006030710.0KCNH2, KCNQ1, SCN5A
15regulation of atrial cardiac muscle cell membrane repolarizationGO:006037210.0KCNQ1, NPPA, SCN5A
16potassium ion transmembrane transportGO:007180510.0KCNH2, KCNJ2, KCNQ1
17regulation of membrane repolarizationGO:006030610.0KCNH2, KCNJ2, KCNQ1
18regulation of ryanodine-sensitive calcium-release channel activityGO:00603149.9CALM2, CALM3
19ventricular cardiac muscle cell action potentialGO:00860059.9KCNH2, KCNQ1, SCN5A
20cardiac conductionGO:00613379.7KCNH2, KCNJ2, KCNQ1, SCN5A
21regulation of heart rate by cardiac conductionGO:00860919.6KCNH2, KCNJ2, KCNQ1, SCN5A
22activation of adenylate cyclase activityGO:00071909.3CALM1, CALM2, CALM3
23detection of calcium ionGO:00055139.2CALM1, CALM2, CALM3
24Fc-epsilon receptor signaling pathwayGO:00380959.2CALM1, CALM2, CALM3
25G2/M transition of mitotic cell cycleGO:00000869.2CALM1, CALM2, CALM3
26glycogen catabolic processGO:00059809.2CALM1, CALM2, CALM3
27inositol phosphate metabolic processGO:00436479.2CALM1, CALM2, CALM3
28ion transmembrane transportGO:00342209.2CALM1, CALM2, CALM3
29muscle contractionGO:00069369.2CALM1, CALM2, CALM3
30negative regulation of peptidyl-threonine phosphorylationGO:00108019.2CALM1, CALM2, CALM3
31negative regulation of ryanodine-sensitive calcium-release channel activityGO:00603159.2CALM1, CALM2, CALM3
32platelet degranulationGO:00025769.2CALM1, CALM2, CALM3
33positive regulation of cyclic nucleotide metabolic processGO:00308019.2CALM1, CALM2, CALM3
34positive regulation of cyclic-nucleotide phosphodiesterase activityGO:00513439.2CALM1, CALM2, CALM3
35positive regulation of DNA bindingGO:00433889.2CALM1, CALM2, CALM3
36positive regulation of nitric-oxide synthase activityGO:00510009.2CALM1, CALM2, CALM3
37positive regulation of peptidyl-threonine phosphorylationGO:00108009.2CALM1, CALM2, CALM3
38positive regulation of phosphoprotein phosphatase activityGO:00325169.2CALM1, CALM2, CALM3
39positive regulation of protein autophosphorylationGO:00319549.2CALM1, CALM2, CALM3
40positive regulation of protein dephosphorylationGO:00353079.2CALM1, CALM2, CALM3
41positive regulation of protein serine/threonine kinase activityGO:00719029.2CALM1, CALM2, CALM3
42positive regulation of ryanodine-sensitive calcium-release channel activityGO:00603169.2CALM1, CALM2, CALM3
43regulation of cardiac muscle contractionGO:00551179.2CALM1, CALM2, CALM3
44regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ionGO:00108819.2CALM1, CALM2, CALM3
45regulation of cell communication by electrical coupling involved in cardiac conductionGO:19018449.2CALM1, CALM2, CALM3
46regulation of cytokinesisGO:00324659.1CALM1, CALM2, CALM3
47regulation of nitric-oxide synthase activityGO:00509999.1CALM1, CALM2, CALM3
48regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulumGO:00108809.1CALM1, CALM2, CALM3
49regulation of rhodopsin mediated signaling pathwayGO:00224009.1CALM1, CALM2, CALM3
50response to amphetamineGO:00019759.1CALM1, CALM2, CALM3

Molecular functions related to Syncope according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1delayed rectifier potassium channel activityGO:000525110.6KCNH2, KCNQ1
2inward rectifier potassium channel activityGO:000524210.5KCNH2, KCNJ2
3enzyme regulator activityGO:003023410.2CALM2, CALM3
4scaffold protein bindingGO:00971109.9KCNH2, KCNQ1, SCN5A
5voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarizationGO:19022829.8KCNH2, KCNQ1
6voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarizationGO:00860089.6KCNH2, KCNJ2, KCNQ1
7adenylate cyclase bindingGO:00081799.3CALM1, CALM2, CALM3
8calcium-dependent protein bindingGO:00483069.3CALM1, CALM2, CALM3
9inositol-1,4,5-trisphosphate 3-kinase activityGO:00084409.3CALM1, CALM2, CALM3
10ligand-gated ion channel activityGO:00152769.3CALM1, CALM2, CALM3
11N-terminal myristoylation domain bindingGO:00319979.3CALM1, CALM2, CALM3
12nitric-oxide synthase regulator activityGO:00302359.3CALM1, CALM2, CALM3
13phosphatidylinositol 3-kinase bindingGO:00435489.3CALM1, CALM2, CALM3
14phospholipase bindingGO:00432749.3CALM1, CALM2, CALM3
15protein phosphatase activator activityGO:00725429.1CALM1, CALM2, CALM3
16protein serine/threonine kinase activator activityGO:00435399.1CALM1, CALM2, CALM3
17Ras guanyl-nucleotide exchange factor activityGO:00050889.0CALM1, CALM2, CALM3
18nitric-oxide synthase bindingGO:00509989.0CALM1, CALM2, CALM3, SCN5A
19thioesterase bindingGO:00319968.9CALM1, CALM2, CALM3
20titin bindingGO:00314328.8CALM1, CALM2, CALM3
21type 3 metabotropic glutamate receptor bindingGO:00318008.8CALM1, CALM2, CALM3
22protein domain specific bindingGO:00199048.8CALM1, CALM2, CALM3, SCN5A
23protein kinase bindingGO:00199018.7CALM1, CALM2, CALM3, SCN5A
24ion channel bindingGO:00443258.6CALM1, CALM2, CALM3, KCNQ1, SCN5A
25protein bindingGO:00055156.5CALM1, CALM2, CALM3, GNB3, KCNH2, KCNJ2

Sources for Syncope

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet